Annabel Kartal-Allen is a London-based reporter writing for Clinical Trials Arena, Pharmaceutical Technology, and Medical Device Network. She focuses on oncology, neurology, and metabolic diseases, and has previously reported on both the pharmaceutical and nutraceutical sectors. Annabel holds a BSc in Biology from the University of Sussex.